ovarian cancer second edition
Ovarian Cancer: Second Edition
$270.00 Original price was: $270.00.$4.99Current price is: $4.99. Add to cart
Sale!

Ovarian Cancer: Second Edition

Original price was: $270.00.Current price is: $4.99.

-98%

Flash Sale: Any ebook for just 4.99 USD only

  • Pay with Any Debit/Credit Card
  • Affordable Prices for Readers
Guaranteed Safe Checkout

The Stealth Malignancy: Ovarian Cancer, Second Edition

Ovarian cancer is the deadliest gynecologic malignancy precisely because it is asymptomatic until it has already ruptured and seeded the entire abdominal cavity with millions of microscopic tumors. Ovarian Cancer: Second Edition is a brutally comprehensive, fiercely multidisciplinary manual detailing the massive surgical and medical effort required to fight this advanced disease. This volume provides the absolute blueprints required to attempt a cure when the cancer has already spread.

Mastering Cytoreductive Surgery

The core philosophy of this text is the absolute necessity of maximal surgical debulking. The authors aggressively detail the sheer scale of the required operation. It dictates exactly how a gynecologic oncologist must not only remove the uterus and ovaries, but physically strip the peritoneum (the lining of the abdomen), resect involved sections of the bowel, and scrape tumors off the diaphragm, because leaving any tumor mass larger than 1 centimeter mathematically guarantees the failure of subsequent chemotherapy.

Navigating the PARP Inhibitor

The book provides a masterclass in exploiting genetic defects. It dictates the exact pharmacological pathways for maintenance therapy. It rigorously explores how a tumor with a BRCA mutation has lost its ability to repair its own DNA, and how drugs like olaparib (PARP inhibitors) intentionally block the cancer’s *backup* repair system, causing the tumor’s DNA to completely shatter and the cells to die, significantly delaying recurrence without the toxicity of standard chemotherapy.

Frequently Asked Questions (FAQs)

Is this an introductory book for general OB/GYNs?
No, it is a highly advanced *gynecologic oncology textbook* focused on the radical surgical procedures and complex chemotherapeutic regimens used for advanced-stage disease.

Who is the primary audience?
It is the absolute, mandatory definitive reference for Gynecologic Oncologists, Medical Oncologists, and Surgical Oncologists.